methylprednisolone and Breast Neoplasms, Male

methylprednisolone has been researched along with Breast Neoplasms, Male in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersen, I; Hansen, B; Hansen, O; Madsen, B; Mathiesen, B; Pfeiffer, P	1

Trials

1 trial(s) available for methylprednisolone and Breast Neoplasms, Male

Article	Year
Sustained-release metoclopramide plus methylprednisolone versus placebo plus methylprednisolone as antiemetic prophylaxis during non-cisplatin chemotherapy. A randomized double-blind cross-over trial. Acta oncologica (Stockholm, Sweden), 1996, Volume: 35, Issue:1 Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Chemoprevention; Cisplatin; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Male; Methylprednisolone; Metoclopramide; Nausea; Ovarian Neoplasms; Self-Assessment; Vomiting	1996

Article

Year

Sustained-release metoclopramide plus methylprednisolone versus placebo plus methylprednisolone as antiemetic prophylaxis during non-cisplatin chemotherapy. A randomized double-blind cross-over trial.

Acta oncologica (Stockholm, Sweden), 1996, Volume: 35, Issue:1

Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Chemoprevention; Cisplatin; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Male; Methylprednisolone; Metoclopramide; Nausea; Ovarian Neoplasms; Self-Assessment; Vomiting

1996